⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Relmada Therapeutics, Inc. Common Stock

$3.30
+0.08 (+2.33%)

Volume:

237.657K ($782.86K)

Market Capitalization:

$351.48M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Relmada Therapeutics Market Segments

Regular Trading Hours

+0.08(+2.33%)
Open$3.22
Close$3.30
Low$3.19
Low Change-0.03 (-0.93%)
High$3.33
High Change+0.11 (+3.42%)
Range$0.14
Volume236.164K
Dollar Volume$778.16K

Premarket

+0.00(+0.00%)
Open$3.15
Close$3.15
Low$3.15
Low Change0.00 (0.00%)
High$3.15
High Change+0.00 (+0.00%)
Range$0.00
Volume1.493K
Dollar Volume$4.70K

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$3.23
Close$3.23
Low$3.23
Low Change0.00 (0.00%)
High$3.23
High Change+0.00 (+0.00%)
Range$0.00
Volume54.371K
Dollar Volume$175.62K

Regular Trading Hours Yesterday

-0.07(-2.13%)
Open$3.29
Close$3.22
Low$3.22
Low Change-0.08 (-2.28%)
High$3.34
High Change+0.05 (+1.52%)
Range$0.13
Volume712.987K
Dollar Volume$2.30M

Premarket Yesterday

*No Trades in Segment

Relmada Therapeutics Top Trades

Relmada Therapeutics's top trade so far today returned +5.71%, while the top short trade returned -1.05%.

Relmada Therapeutics Moving Averages

5 Day Moving Average (SMA5)$3.27
10 Day Moving Average (SMA10)$3.25
20 Day Moving Average (SMA20)$3.36
50 Day Moving Average (SMA50)$3.96
100 Day Moving Average (SMA100)$4.91
200 Day Moving Average (SMA200)$5.37

Relmada Therapeutics Statistics

Average Volume (30 Days)1.31M
P/E Ratio (Current)-5.84
EPS (Current)-$0.58
Dividend Yield0.00%
Free Cash Flow-$45.99M
Cash Ratio1.53
Current Ratio29.52
Quick Ratio29.52
Debt to Equity0.00
Enterprise Value$350.28M
EV to EBITDA-5.38
EV to Sales—
Price to Book1.75
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.28%
Return on Equity-0.30%

Relmada Therapeutics Stock Splits

There have been 2 stock splits for Relmada Therapeutics (RLMD). The last reverse stock split occured on September 30, 2019 and reduced the outstanding shares at a ratio of 4:1.

DateTypeRatio
Sep 30, 2019Reverse4:1
Aug 12, 2015Reverse5:1

Relmada Therapeutics Dividends

There have been no dividends for Relmada Therapeutics (RLMD).